Sebastian Aguirre Kozlouski

Company: Carbon Biosciences

Job title: Co-Founder, Vice President, Head of Platform Development

Seminars:

Extending the Reach of Genetic Medicine Through Next-Generation Parvovirus Vector Technology 12:00 pm

A comparison of LNPs and AAVs reveals key differences in immunogenicity and toxicity, suggesting potential benefits of combined use Improved targeting and uptake strategies aim to mitigate immune responses and toxicity in metabolic liver diseases Overcoming delivery challenges, for LNPs to be optimized for more effective transport of therapies to liver cellsRead more

day: Day 1- Translation 1